Home

Quick Links

Legal

navigation
Home > Trends & Insights > Biopharma Firm Restarts With Fresh Capital And New Technology

Case Studies

Tuesday, October 1, 2019

blog

Biopharma Firm Restarts With Fresh Capital And New Technology


  • Challenge: Chapter 11 bankruptcy
  • Solution: Senior finance and accounting support through the bankruptcy and operational support to help the firm reorganize and restart
  • Result: The firm reorganized and restarted with fresh capital and newly acquired technology under court supervision

This early-stage public biopharma company engaged a CFO and a controller from Armanino to assist the board and shareholders in managing the company through a Chapter 11 debtor-in-possession bankruptcy.

The team worked with insolvency counsel, interfaced with the trustee, and represented the company on numerous occasions in bankruptcy court in Delaware to provide senior finance and accounting support through the Chapter 11 process. In addition, the team provided operational support for the company as it reorganized, relocated and restarted with fresh capital and newly acquired drug technology under court supervision.


Contact an Armanino Expert:

Michael Hogan - Managing Director, Consulting

Alex van Dillen - Director, Consulting


COMMENTS

comments powered by Disqus